Skip to Main Content
John F. Kaschak
John F. Kaschak
Associate
Parsippany, NJ
| (973) 966-8034

Overview

John Kaschak represents corporate clients in the technology, healthcare, life sciences, manufacturing and energy industries. He advises clients on transactional, corporate and regulatory matters, including technology and intellectual property licensing, mergers, acquisitions and joint ventures, venture capital financings, commercial agreements, corporate governance, and state and federal regulatory compliance matters in the areas of technology and data privacy.

John also provides support to in-house counsels on day-to-day legal matters and regularly assists clients with drafting and negotiating agreements. He has extensive experience with technology services agreements, licensing agreements, product sales and distribution agreements; SaaS, PaaS and IaaS agreements; and other commercial agreements. John helps clients structure these deals to mitigate risks while achieving their business objectives.

During and prior to law school, John worked in the finance departments of a Global 500 company and a Fortune 500 company, where he performed financial analysis and worked with business partners to help drive earnings and profitability.

Education and Credentials

Education

  • Seton Hall University School of Law, J.D., Salutatorian, summa cum laude, Order of the Coif, Seton Hall Law Review
  • Franklin and Marshall College, B.A., Business, Organizations and Society, cum laude

Admissions

  • State of New Jersey

In The Media

Media Mention

John F. Kaschak Latest News and Insights

April 25, 2024
Certain ASCs Face New Prior Authorization Payment Requirements from CMS

Day Pitney Cybersecurity, Healthcare and Technology (C.H.A.T.) Newsletter –  April 2024

April 25, 2024
Generative Artificial Intelligence Representations and Warranties Emerge in Venture Financing Transactions

Day Pitney Cybersecurity, Healthcare and Technology (C.H.A.T.) Newsletter –  April 2024

February 28, 2024
HHS Issues Long-Awaited Final Rule Modifying Part 2 Regulations

Day Pitney Cybersecurity, Healthcare and Technology (C.H.A.T.) Newsletter –  February 2024

February 28, 2024
New DOJ Safe Harbor Policy for Voluntary Self-Disclosures in M&A Transactions—What You Should Know

Day Pitney Cybersecurity, Healthcare and Technology (C.H.A.T.) Newsletter –  February 2024

December 20, 2023
New Providers/Entrants Beware – Ignorance Is Not a Defense

Day Pitney Cybersecurity, Healthcare and Technology (C.H.A.T.) Newsletter –  December 2023

EMAIL DISCLAIMER

Thank you for your interest in contacting us by email.

Your e-mail to this individual should not contain any confidential information and should be for general information purposes only. An attorney-client relationship will not be created by your e-mail to this individual. Information in your e-mail may not be entitled to any protections commonly associated with communications with attorneys. If you are in doubt about any information, please exclude it.

If you accept the terms of this notice and would like to send an email, click on the "I Agree" button below. Otherwise, please click "I Don't Agree".